| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enveric Biosciences, Inc. (ENVB) has 8 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. ENVB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 70.4K | $200.5K | - | |
| CFO | 47.4K | $135.1K | - | |
| Other | 33.1K | $94.2K | - | |
| Dir | 7.9K | $22.5K | - | |
| Dir | 7.9K | $22.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2017 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 7,500 | $6.50 | $48,750.00 | +288.0% | |
| Aug 21, 2017 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 2,604 | $6.50 | $16,924.44 | New | |
| Mar 30, 2017 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 223 | $6.51 | $1,451.73 | +0.3% | |
| Feb 10, 2017 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 434 | $6.51 | $2,825.34 | +0.5% | |
| Jan 23, 2017 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 2,130 | $6.51 | $13,866.30 | +2.7% | |
| Jan 18, 2017 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 10,000 | $6.51 | $65,100.00 | +14.3% | |
| Dec 30, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 40 | $6.51 | $260.40 | - | |
| Dec 29, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 1,506 | $6.51 | $9,804.06 | +1.1% | |
| Dec 22, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 700 | $6.51 | $4,557.00 | +1.0% | |
| Dec 2, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 808 | $6.51 | $5,260.08 | +0.6% |